{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:28:03Z","timestamp":1791224883357,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T00:00:00Z","timestamp":1158710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/sj.npp.1301207","type":"journal-article","created":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T06:50:06Z","timestamp":1158735006000},"page":"2767-2775","source":"Crossref","is-referenced-by-count":44,"title":["Enhanced Sensitivity to the Euphoric Effects of Alcohol in Schizophrenia"],"prefix":"10.1038","volume":"31","author":[{"given":"Deepak C","family":"D'Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto B","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Madonick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberlee","family":"Forselius-Bielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Braley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Tellioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Zimolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralitza","family":"Gueorguieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,20]]},"reference":[{"key":"BF1301207_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","volume":"25","author":"FM Benes","year":"2001","unstructured":"Benes FM, Berretta S (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25: 1\u201327.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301207_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/01688639208402862","volume":"14","author":"J Brandt","year":"1992","unstructured":"Brandt J, Corwin J, Krafft L (1992). Is verbal recognition memory really different in Huntington's and Alzheimer's disease. J Clin Exp Neuropsychol 14: 773\u2013784.","journal-title":"J Clin Exp Neuropsychol"},{"key":"BF1301207_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1024465317902","volume":"11","author":"JD Bremner","year":"1998","unstructured":"Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS et al (1998). Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Traumatic Stress 11: 125\u2013136.","journal-title":"J Traumatic Stress"},{"key":"BF1301207_CR4","volume-title":"Nonparametric Analysis of Longitudinal Data in Factorial Experiments","author":"EDS Brunner","year":"2002","unstructured":"Brunner EDS, Langer F (2002). Nonparametric Analysis of Longitudinal Data in Factorial Experiments. John Wiley and Sons: New York."},{"key":"BF1301207_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","volume":"50","author":"RA Chambers","year":"2001","unstructured":"Chambers RA, Krystal JH, Self DW (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50: 71\u201383.","journal-title":"Biol Psychiatry"},{"key":"BF1301207_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0376-8716(94)90163-5","volume":"34","author":"MA Chutuape","year":"1994","unstructured":"Chutuape MA, de Wit H (1994). Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend 34: 243\u2013251.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301207_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00005053-199406000-00006","volume":"182","author":"BJ Cuffel","year":"1994","unstructured":"Cuffel BJ, Chase P (1994). Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study. J Nerv Mental Dis 182: 342\u2013348.","journal-title":"J Nerv Mental Dis"},{"key":"BF1301207_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","volume":"57","author":"DC D'Souza","year":"2005","unstructured":"D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G et al (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57: 594\u2013608.","journal-title":"Biol Psychiatry"},{"key":"BF1301207_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1530-0277.1987.tb01263.x","volume":"11","author":"H de Wit","year":"1987","unstructured":"de Wit H, Uhlenhuth EH, Pierri J, Johanson CE (1987). Individual differences in behavioral and subjective responses to alcohol. Alcohol Clin Exp Res 11: 52\u201359.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1301207_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1037\/h0080153","volume":"66","author":"RE Drake","year":"1996","unstructured":"Drake RE, Mueser KT, Clark RE, Wallach MA (1996). The course, treatment, and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry 66: 42\u201351.","journal-title":"Am J Orthopsychiatry"},{"key":"BF1301207_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/00005053-198907000-00004","volume":"177","author":"RE Drake","year":"1989","unstructured":"Drake RE, Osher FC, Wallach MA (1989). Alcohol use and abuse in schizophrenia. A prospective community study. J Nerv Mental Dis 177: 408\u2013414.","journal-title":"J Nerv Mental Dis"},{"key":"BF1301207_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/oxfordjournals.schbul.a033464","volume":"26","author":"RE Drake","year":"2000","unstructured":"Drake RE, Xie H, McHugo GJ, Green AI (2000). The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 26: 441\u2013449.","journal-title":"Schizophr Bull"},{"key":"BF1301207_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00008877-199811000-00019","volume":"9","author":"T Duka","year":"1998","unstructured":"Duka T, Tasker R, Stephens DN (1998). Alcohol choice and outcome expectancies in social drinkers. Behav Pharmacol 9: 643\u2013653.","journal-title":"Behav Pharmacol"},{"key":"BF1301207_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1037\/0893-164X.15.3.204","volume":"15","author":"J Erblich","year":"2001","unstructured":"Erblich J, Earleywine M, Erblich B (2001). Positive and negative associations with alcohol and familial risk for alcoholism. Psychol Addict Behav 15: 204\u2013209.","journal-title":"Psychol Addict Behav"},{"key":"BF1301207_CR15","first-page":"288","volume":"22","author":"M Gordon","year":"1986","unstructured":"Gordon M (1986). Microprocessor-based assessment of attention deficit disorders (ADD). Psychopharmacol Bull 22: 288\u2013290.","journal-title":"Psychopharmacol Bull"},{"issue":"Suppl 6","key":"BF1301207_CR16","first-page":"21","volume":"66","author":"AI Green","year":"2005","unstructured":"Green AI (2005). Schizophrenia and comorbid substance use disorder: effects of antipsychotics. J Clin Psychiatry 66 (Suppl 6): 21\u201326.","journal-title":"J Clin Psychiatry"},{"key":"BF1301207_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0920-9964(02)00231-1","volume":"60","author":"AI Green","year":"2003","unstructured":"Green AI, Burgess ES, Dawson R, Zimmet SV, Strous RD (2003). Alcohol and cannabis use in schizophrenia: effects of clozapine vs risperidone. Schizophr Res 60: 81\u201385.","journal-title":"Schizophr Res"},{"key":"BF1301207_CR18","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1111\/j.1530-0277.1998.tb05897.x","volume":"22","author":"L Holdstock","year":"1998","unstructured":"Holdstock L, de Wit H (1998). Individual differences in the biphasic effects of ethanol. Alcohol Clin Exp Res 22: 1903\u20131911.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1301207_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/10673229709030550","volume":"4","author":"EJ Khantzian","year":"1997","unstructured":"Khantzian EJ (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 4: 231\u2013244.","journal-title":"Harv Rev Psychiatry"},{"key":"BF1301207_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","volume":"169","author":"JH Krystal","year":"2003","unstructured":"Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berlin) 169: 215\u2013233.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF1301207_CR21","volume-title":"Ethanol Abuse, Dependence, and Withdrawal: Neurobiology and Clinical Implications","author":"JH Krystal","year":"2002","unstructured":"Krystal JH, Tabakoff B (2002). Ethanol Abuse, Dependence, and Withdrawal: Neurobiology and Clinical Implications. Lippincott Williams and Wilkins: Philadelphia."},{"key":"BF1301207_CR22","first-page":"1182","volume":"36","author":"M Laruelle","year":"1995","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS et al (1995). SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36: 1182\u20131190.","journal-title":"J Nucl Med"},{"key":"BF1301207_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.15288\/jsa.1980.41.871","volume":"41","author":"DM Lawson","year":"1980","unstructured":"Lawson DM, Nathan PE, Lipscomb TR (1980). Guidelines for the administration of alcohol to human subjects in behavioral research. J Stud Alcohol 41: 871\u2013881.","journal-title":"J Stud Alcohol"},{"key":"BF1301207_CR24","first-page":"209","volume":"24","author":"PA Madden","year":"2000","unstructured":"Madden PA, Bucholz KK, Martin NG, Heath AC (2000). Smoking and the genetic contribution to alcohol-dependence risk. Alcohol Res Health 24: 209\u2013214.","journal-title":"Alcohol Res Health"},{"key":"BF1301207_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1530-0277.1995.tb01588.x","volume":"19","author":"PA Madden","year":"1995","unstructured":"Madden PA, Heath AC, Starmer GA, Whitfield JB, Martin NG (1995). Alcohol sensitivity and smoking history in men and women. Alcohol Clin Exp Res 19: 1111\u20131120.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1301207_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1530-0277.1993.tb00739.x","volume":"17","author":"CS Martin","year":"1993","unstructured":"Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM (1993). Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res 17: 140\u2013146.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1301207_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1037\/0033-2909.108.3.383","volume":"108","author":"DB Newlin","year":"1990","unstructured":"Newlin DB, Thomson JB (1990). Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychol Bull 108: 383\u2013402.","journal-title":"Psychol Bull"},{"key":"BF1301207_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00005053-199107000-00004","volume":"179","author":"DL Noordsy","year":"1991","unstructured":"Noordsy DL, Drake RE, Teague GB, Osher FC, Hurlbut SC, Beaudett MS et al (1991). Subjective experiences related to alcohol use among schizophrenics (comment). J Nerv Mental Dis 179: 410\u2013414.","journal-title":"J Nerv Mental Dis"},{"key":"BF1301207_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962). The Brief Psychiatric Rating Scale: a comprehensive review. Psychol Reprints 10: 799\u2013812.","journal-title":"Psychol Reprints"},{"key":"BF1301207_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.15288\/jsa.1996.57.368","volume":"57","author":"MA Schuckit","year":"1996","unstructured":"Schuckit MA, Tsuang JW, Anthenelli RM, Tipp JE, Nurnberger Jr JI (1996). Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J Stud Alcohol 57: 368\u2013377.","journal-title":"J Stud Alcohol"},{"key":"BF1301207_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0306-4603(92)90011-J","volume":"17","author":"LC Sobell","year":"1992","unstructured":"Sobell LC, Toneatto T, Sobell MB, Leo GI, Johnson L (1992). Alcohol abusers' perceptions of the accuracy of their self-reports of drinking: implications for treatment. Addict Behav 17: 507\u2013511.","journal-title":"Addict Behav"},{"key":"BF1301207_CR32","volume-title":"Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P, Version 1.0)","author":"RL Spitzer","year":"1990","unstructured":"Spitzer RL, Williams JBW, Gibbon M, First MB (1990). Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P, Version 1.0). American Psychiatric Press: Washington, DC."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301207","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:52:35Z","timestamp":1684219955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,20]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["BF1301207"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301207","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,20]]}}}